Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease

Transplantation

Volumn 81, Issue 8, 2006, Pages 1087-1092

  Colombo, Anna A ^a,b   Rusconi, Chiara ^a   Esposito, Ciro ^a   Bernasconi, Paolo ^a   Caldera, Daniela ^a   Lazzarino, Mario ^a   Alessandrino, Emilio P ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Allo HSCT; Chronic GVHD; Nephrotic syndrome

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE; PREDNISONE; STEROID;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CLINICAL FEATURE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL;

ADULT; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 33646812198     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000209496.26639.cb     Document Type: Article

References (35)

1. Imai H, Oyama Y, Miura AB, et al. Hematopoietic cell transplantation- related nephropathy in Japan. Am J Kidney Dis 2000; 36: 474-480.
2. Oliveira JSR, Bahia D, Balda C, et al. Nephrotic syndrome as a clinical manifestation of graft-versus host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal. Bone Marrow Transplant 1999; 23: 99-101.
3. Barbara J, Thomas AC, Smith PS, et al. Membranous nephropathy with graft-versus-host disease in a bone marrow transplant recipient. Clin Nephr 1992; 37: 115-118.
4. Gomez-Garcia, Herrera-Arroyo C, Torres-Gomez A, et al. Renal involvement in chronic graft versus host disease: a report of two cases. Bone Marrow Transplant 1988; 3: 357-362.
5. Ikee R, Yamamoto K, Kushiyama T, et al. Recurrent nephrotic syndrome associated with graft-versus-host disease. Bone Marrow Transplant 2004; 34: 1005-1006.
6. Lin J, Markowitz GS, Nicolaides M, et al. Membranous glomerulopathy associated with graft versus host disease following allogeneic stem cell transplantation. Report of 2 cases and review of the literature. Am J Nephrol 2001; 21: 351-356.
7. Miyazaki Y, Mori Y, Kishimoto N, et al. Membranous nephropathy associated with donor lymphocytes infusion following allogeneic bone marrow transplantation. Int J Hematol 2003; 78: 262-265.
8. Nergizoglu G, Keven K, Ates K, et al. Chronic graft versus host disease complicated by membranous glomerulonephritis. Nephr Dial Transplant 1999; 14: 2461-2463.
9. Rao PS. Nephrotic syndrome in patients with peripheral blood stem cell transplant. Am J Kidney Dis 2005; 45: 780-785.
10. Sato N, Kishi K, Yagisawa K, et al. Nephrotic syndrome in a bone marrow transplant recipient with chronic graft disease. Bone Marrow Transplant 1995; 16: 303-305.
11. Yorioka N, Taniguchi Y, Shimote K, et al. Membranous nephropathy with chronic graft versus host disease in a bone marrow transplant recipient. Nephron 1998; 80: 371-372.
12. Ratanatharathorn L, Ayash Lazarus BHM, et al. Chronic graft versus host disease: clinical manifestation and therapy. Bone Marrow Transplant 2001; 28: 121-129.
13. Sullivan KM, Shulman HM, Storb R, et al. Chronic graft versus host disease in 52 patients: adverse natural course and successful treatment with combination immuno-suppression. Blood 1981; 57: 267-276.
14. Alessandrino EP, Bernasconi P, Colombo AA, et al. Reduced intensity conditioning regimen with thiotepa and fludarabine followed by allogenic blood stem cell transplantation in hematological malignancy. Bone Marrow Transplant 2004; 34: 1039-1045.
15. Akar H, Keven K, Celebi H, et al. Nephrotic syndrome after allogeneic peripheral blood stem cell transplantation. J Nephrol 2002; 15: 79-82.
16. Hiesse C, Goldschmidt E, Santelli G, et al. Membranous nephropathy in a bone marrow recipient. Am J Kidney Dis 1988; 11: 188.
17. Kim KW, Yoon CH, Kay CS, et al. Membranous nephropathy after hemopoietic stem cell transplantation in a patient with aplastic anemia. J Korean Med Sci 2003; 18: 287-289.
18. Kimura S, Horie A, Hiki Y, et al. Nephrotic syndrome with crescent formation and massive IgA deposition following allogeneic bone marrow transplantation for natural killer cell leukemia/lymphoma. Blood 2003; 101: 4219-4221.
19. Muller GA, Muller Ca, Markovic-Lipkowski J, et al. Membranous nephropathy after bone marrow transplantation in cyclosporin treatment. Nephron 1989; 51: 555-556.
20. Sato Y, Hara S, Fujimoto S, et al. Minimal change nephrotic syndrome after allogenic hematopoietic stem cell transplantation. Int Med 2004; 43: 512-515.
21. Stevenson WS, Nankivell BJ, Hertzberg MS. Nephrotic syndrome after stem cell transplantation. Clin Transplant 2005; 19: 141-144.
22. Tsutsumi C, Miyazaki Y, Fukshima T, et al. Membranous nephropathy after allogeneic stem cell transplantation. Int J Hematol 2004; 79: 193-197.
23. Walker JV, Morich D, Anasetti C, et al. Minimal change nephrotic syndrome after cyclosporine withdrawal in a marrow transplant recipient. Am J Kidney Dis 1995; 26: 532-534.
24. Yabana M, Takogi N, Kihara M, et al. A case of nephrotic syndrome after bone marrow transplantation. Nippon Jinzo Gakkai Shi 1997; 39: 414-420.
25. Storek J, Gooley T, Siadak M, et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft versus host disease. Blood 1997; 90: 4705-4709.
26. Tayeby H, Lapierre V, Saas P, et al. Enhanced activation of B cells in a granulocyte colony-stimulating factor-mobilized peripheral blood stem cell graft. Br J Haematol 2001; 114: 698-700.
27. Bruijin JA, van Elven EH, Hogendoorn PCW, et al. Murine chronic graft versus host disease as a model for lupus nephritis. Am J Pathol 1988; 130: 639-641.
28. Kitching AR. Cytokines T cells and proliterative glomerulonephritis. Nephrology 2002; 7: 244-249.
29. Seconi J, Watt V, Ritchie DS. Nephrotic syndrome following allogeneic stem cell transplantation associated with increase production of TNF-alfa, and interferon gamma by donor T cells. Bone Marrow Transplant 2003; 32: 447-450.
30. Shustov A. Role of perform in controlling B-cell hyperactivity and humoral autoimmunity. J Clin Invest 2000; 106: 39-47.
31. Short CD, Mallick NP, et al. Membranous nephropathy. In: Schrier RW, Gottschalk CW (eds): Disease of the Kidney. Boston: Little, Brown and Company; 1997: 1693-1723.
32. Canniga-Van Dijk MR, Van der Straaten HM, Fijnheer R, et al. Anti CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus host disease. Blood 2004; 104: 2603-2606.
33. Cottrain DC, Wald R, Brenchey PEC, Coupe B. Clinical correlates of serial urinary membrane attack complex estimates in patients with idiopathic membranous nephropathy. Clinical Nephrology 2003; 60: 7-12.
34. Ponticelli C, Passerini P. Treatment of membranous nephropathy. Nephrol Dial Transplant 2001; 16: 8-10.
35. Perna A, Schieppati A, Zamora J, et al. Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review. Am J Kidney Dis 2004; 44: 562-566.